BioNTech Q4 Earnings, Revenue Decline; 2025 Outlook Issued

MT Newswires Live

2025/03/10

BioNTech (BNTX) reported Q4 earnings Monday of 1.08 euros ($1.17) per diluted share, down from 1.88 euros a year earlier.

Comparable analyst estimates were not readily available.

Revenue for the quarter ended Dec. 31 was 1.19 billion euros, down from 1.48 billion euros a year earlier.

Analysts surveyed by FactSet expected 1.09 billion euros.

For 2025, the biotech firm expects revenue of 1.70 billion euros to 2.20 billion euros. Analysts polled by FactSet expect 2.54 billion euros.

Shares of the company were down more than 2.6% in recent premarket activity Monday.

Price: 106.00, Change: -2.78, Percent Change: -2.56

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2518244786"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2518244786\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2518244786?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-10 19:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2518244786","market":"sg","top_or_hot":-1,"title":"BioNTech Q4 Earnings, Revenue Decline; 2025 Outlook Issued","media":"MT Newswires Live","content":"<html><body><p> BioNTech (BNTX) reported Q4 earnings Monday of 1.08 euros ($1.17) per diluted share, down from 1.88 euros a year earlier.</p><p>Comparable analyst estimates were not readily available.</p><p>Revenue for the quarter ended Dec. 31 was 1.19 billion euros, down from 1.48 billion euros a year earlier.</p><p>Analysts surveyed by FactSet expected 1.09 billion euros.</p><p>For 2025, the biotech firm expects revenue of 1.70 billion euros to 2.20 billion euros. Analysts polled by FactSet expect 2.54 billion euros.</p><p>Shares of the company were down more than 2.6% in recent premarket activity Monday.</p><p>Price: 106.00, Change: -2.78, Percent Change: -2.56</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech Q4 Earnings, Revenue Decline; 2025 Outlook Issued</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech Q4 Earnings, Revenue Decline; 2025 Outlook Issued\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-03-10 19:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> BioNTech (BNTX) reported Q4 earnings Monday of 1.08 euros ($1.17) per diluted share, down from 1.88 euros a year earlier.</p><p>Comparable analyst estimates were not readily available.</p><p>Revenue for the quarter ended Dec. 31 was 1.19 billion euros, down from 1.48 billion euros a year earlier.</p><p>Analysts surveyed by FactSet expected 1.09 billion euros.</p><p>For 2025, the biotech firm expects revenue of 1.70 billion euros to 2.20 billion euros. Analysts polled by FactSet expect 2.54 billion euros.</p><p>Shares of the company were down more than 2.6% in recent premarket activity Monday.</p><p>Price: 106.00, Change: -2.78, Percent Change: -2.56</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BNTX","symbol_name":"BioNTech SE","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2518244786","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2518244786","pubTimestamp":1741605087,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"BioNTech  reported Q4 earnings Monday of 1.08 euros  per diluted share, down from 1.88 euros a year earlier.Comparable analyst estimates were not readily available.Revenue for the quarter ended Dec. 31 was 1.19 billion euros, down from 1.48 billion euros a year earlier.Analysts surveyed by FactSet expected 1.09 billion euros.For 2025, the biotech firm expects revenue of 1.70 billion euros to 2.20 billion euros. Analysts polled by FactSet expect 2.54 billion euros.Shares of the company were down more than 2.6% in recent premarket activity Monday.Price: 106.00, Change: -2.78, Percent Change: -2.56","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BNTX":"BioNTech SE"},"translate_title":"BioNTech第四季度盈利、收入下降；发布2025年展望","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNTX":0.6},"content_text":"BioNTech (BNTX) reported Q4 earnings Monday of 1.08 euros ($1.17) per diluted share, down from 1.88 euros a year earlier.Comparable analyst estimates were not readily available.Revenue for the quarter ended Dec. 31 was 1.19 billion euros, down from 1.48 billion euros a year earlier.Analysts surveyed by FactSet expected 1.09 billion euros.For 2025, the biotech firm expects revenue of 1.70 billion euros to 2.20 billion euros. Analysts polled by FactSet expect 2.54 billion euros.Shares of the company were down more than 2.6% in recent premarket activity Monday.Price: 106.00, Change: -2.78, Percent Change: -2.56","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}